Category: Vaccine

The Veracity of VAERS

An escalating information war is pitting the “vaxxed” against the “unvaxxed” over the safety of the three COVID-19 vaccines being administered in the United States. In 2021, a massive spike in reporting was seen in the Vaccine Adverse Event Reporting System (VAERS), the main vaccine side effect and injury reporting site in the United States….


Pfizer Forecasts $54 Billion in Sales This Year as Demand for COVID-19 Vaccine and Treatment Pill Continues

Pfizer on Tuesday said it expects to see continued demand for its products this year, forecasting $54 billion in combined sales of its COVID-19 vaccine shots and antiviral pills. The American pharmaceutical and biotechnology giant said it expects to sell $32 billion of its vaccinations and $22 billion of its antiviral COVID-19 treatment pill Paxlovid in…


Pfizer Reports Bumper Income from COVID-19 Vaccine Sales In 2021, But Forecasts for 2022 Disappoint

Pfizer’s COVID-19 vaccine brought in a bumper income of nearly $37 billion in sales for 2021, the product’s first full year on the market, though Pfizer’s revenue forecasts for 2022 came in below analysts’ expectations, sending its shares down by over 5 percent. Called Comirnaty, the company’s two-dose COVID-19 vaccine generated $36.78 billion in revenue…


Pfizer Reports Nearly 37 Billion in COVID-19 Vaccine Sales Last Year

Pfizer’s COVID-19 vaccine brought in a bumper income of nearly $37 billion in sales for 2021, the product’s first full year on the market, though Pfizer’s revenue forecasts for 2022 came in below analysts’ expectations, sending its shares down by over 5 percent. Called Comirnaty, the company’s two-dose COVID-19 vaccine generated $36.78 billion in revenue…


CDC Signals Changes to COVID-19 Vaccine Schedule, in Part to Address Heart Inflammation

The Centers for Disease Control and Prevention (CDC) on Feb. 4 outlined an expected change to the COVID-19 vaccine schedule for people with weak immune systems and signaled that a different alteration is coming for the general population to try to cut the number of post-vaccination heart inflammation cases. The CDC told its vaccine advisory…


Fired Syneos Health Workers: Company Ignored Tennessee Vaccination Law

When Syneos Health fired employees who refused to get vaccinated for COVID-19, it allowed Florida residents to keep working. Presumably, the company was following Florida’s law, enacted in November, prohibiting private employers from mandating COVID-19 vaccines. Under Florida’s law, businesses with 99 employees or less face a fine of $10,000 per employee violation, while larger…


4 in 10 COVID-19 Patients in California Hospital Fully Vaccinated After Omicron Emergence: Study

Some four in 10 COVID-19 patients in a hospital in California during late December 2021 and most of January were fully vaccinated, according to a new study. The percentage of fully patients in an academic hospital in California climbed from 25 percent in the summer of 2021 to 40 percent after the Omicron virus variant…


16 States File New Challenge to Biden Administration’s Health Care Worker COVID-19 Vaccine Mandate

Louisiana and 15 other states on Friday lodged a new legal challenge against the federal government’s COVID-19 vaccine mandate for health care workers, arguing the dominance of the Omicron virus variant undercuts the justification for the mandate. Approximately 10.4 million workers fall under the vaccination requirements, which apply to every facility that receives Medicare or…


CDC Advisory Panel Recommends Moderna’s COVID-19 Vaccine for All Adults

A Centers for Disease Disease Control and Prevention (CDC) advisory panel on Feb. 4 unanimously recommended Moderna’s COVID-19 vaccine for all adults. All 13 members of the Advisory Committee on Immunization Practices voted after hearing presentations from CDC officials on safety and efficacy data for the vaccine, which was approved by U.S. drug regulators on Jan….


FDA Requested COVID-19 Vaccine Data for Young Children to Prepare for Any ‘Twist’ in Pandemic: Official

The Food and Drug Administration (FDA) took the unusual step of requesting data from Pfizer and BioNTech on how its vaccine has been doing in a clinical trial because of the surge in pediatric COVID-19 hospitalizations and wanting to prepare for the next “twist” in the pandemic, an FDA official said on Feb. 4. “As…